Flu vaccine studies that are funded by industry are significantly more likely to be published in prestigious journals and to later be cited in the scientific literature than studies without such funding, according to a survey of 274 studies conducted by researchers from the Cochrane Vaccine Field in Italy, and published in the British Medical Journal.
Overall, the authors also found that most flu vaccine studies were of poor quality, with only 18 percent of them reporting conclusions that were actually supported by their findings (concordance).
To accomplish its mission of increasing the health security of the U.S., the Centers for Disease...
The Food and Drug Administration (FDA) announced on Tuesday that it will limit access to seasonal...
Wait, aren't "clean" rooms supposed to be, well, "clean" of germs and other pesky microscopic particles?
Maybe...
